A detailed history of Toronto Dominion Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Toronto Dominion Bank holds 17,929 shares of AZN stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,929
Previous 17,929 -0.0%
Holding current value
$1.2 Million
Previous $1.4 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $184,621 - $210,988
2,408 Added 15.51%
17,929 $1.4 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $198,559 - $240,226
-2,972 Reduced 16.07%
15,521 $1.21 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $149,340 - $170,237
2,447 Added 15.25%
18,493 $1.25 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $475,624 - $532,416
7,685 Added 91.91%
16,046 $1.08 Million
Q3 2023

Feb 14, 2024

BUY
$64.85 - $71.7 $271,916 - $300,638
4,193 Added 100.6%
8,361 $566,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $271,916 - $300,638
4,193 Added 100.6%
8,361 $566,000
Q2 2023

Feb 14, 2024

SELL
$69.91 - $75.81 $830,390 - $900,471
-11,878 Reduced 74.02%
4,168 $299,000
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $65,995 - $71,564
944 Added 29.28%
4,168 $299,000
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $33,911 - $38,449
537 Added 19.99%
3,224 $224,000
Q4 2022

Feb 07, 2023

SELL
$54.21 - $70.44 $2,764 - $3,592
-51 Reduced 1.86%
2,687 $182,000
Q3 2022

Nov 09, 2022

BUY
$53.02 - $135.75 $22,480 - $57,558
424 Added 18.32%
2,738 $150,000
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $35,911 - $43,110
606 Added 35.48%
2,314 $153,000
Q1 2022

May 09, 2022

BUY
$55.72 - $67.12 $28,305 - $34,096
508 Added 42.33%
1,708 $113,000
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $58,104 - $72,216
1,200 New
1,200 $72,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.